A FORMER Ballarat woman backed by billionaire Bill Gates to help mothers in developing countries will speak at a University of Ballarat Technology Park breakfast this month.
Subscribe now for unlimited access.
$0/
(min cost $0)
or signup to continue reading
Monash Institute of Pharmaceutical Sciences senior lecturer Michelle McIntosh is developing an inhaleable form of the drug oxytocin, backed, in part, by a grant from the Bill and Melinda Gates Foundation.
Oxytocin stops excessive bleeding after childbirth, reducing postpartum fatalities. As a powder, the drug could be self-administered in remote areas .
At the UB lecture, Dr McIntosh says she will discuss the potential to make "a tangible difference" in the quality of women's healthcare.
"The World Health Organisation (WHO) recommends that every woman receives a dose of oxytocin after giving birth," she says.
"I'm trying to make sure women in all countries have that opportunity."